[{"id":"337d5bf7-588a-4338-b1ad-206b4cae5557","acronym":"","url":"https://clinicaltrials.gov/study/NCT02241369","created_at":"2021-06-23T19:53:14.793Z","updated_at":"2024-07-02T16:37:05.237Z","phase":"Phase 1","brief_title":"Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies","source_id_and_acronym":"NCT02241369","lead_sponsor":"Inovio Pharmaceuticals","biomarkers":" IFNG","pipe":"","alterations":" ","tags":["IFNG"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e rocakinogene sifuplasmid (INO-9012) • INO-3106"],"overall_status":"Completed","enrollment":" Enrollment 3","initiation":"Initiation: 05/01/2014","start_date":" 05/01/2014","primary_txt":" Primary completion: 09/01/2018","primary_completion_date":" 09/01/2018","study_txt":" Completion: 09/01/2018","study_completion_date":" 09/01/2018","last_update_posted":"2018-11-16"}]